COVIran Barekat (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "COVIran Barekat" in English language version.

refsWebsite

Global rank English rank

31web.archive.org

1^st place

9nih.gov

4^th place

7tehrantimes.com

4,540^th place

3,354^th place

6doi.org

2^nd place

6tasnimnews.com

995^th place

4,729^th place

6irna.ir

643^rd place

5,316^th place

5setad.ir

low place

5irct.ir

low place

5isna.ir

422^nd place

5,832^nd place

4farsnews.ir

1,083^rd place

8,125^th place

3shifapharmed.com

low place

2semanticscholar.org

11^th place

8^th place

2aljazeera.com

268^th place

215^th place

2reuters.com

49^th place

47^th place

2yjc.ir

1,498^th place

low place

2yjc.news

4,172^nd place

low place

1harvard.edu

18^th place

17^th place

1trend.az

4,569^th place

6,803^rd place

1indiatimes.com

17^th place

15^th place

1bbc.com

20^th place

30^th place

1tums.ac.ir

low place

1mehrnews.com

540^th place

4,672^nd place

1khabaronline.ir

837^th place

low place

1mojnews.com

9,979^th place

low place

1irinn.ir

low place

1latimes.com

22^nd place

19^th place

1iranwire.com

3,848^th place

low place

1timesofisrael.com

571^st place

403^rd place

1irannewspaper.ir

low place

1bmj.com

1,226^th place

1,421^st place

1radiofarda.com

577^th place

6,647^th place

1bloomberg.com

99^th place

77^th place

1iranpress.com

low place

1efe.com

2,412^th place

4,326^th place

1nicaraguaactual.tv

low place

1el19digital.com

low place

1who.int

195^th place

302^nd place

1france24.com

481^st place

508^th place

1alef.ir

5,662^nd place

low place

1mashreghnews.ir

2,084^th place

8,749^th place

1washingtonpost.com

34^th place

27^th place

alef.ir

"علی لاریجانی واکسن ایرانی تزریق کرد" [Ali Larijani is injected with the Iranian vaccine]. جامعه خبری تحلیلی الف (in Persian). 2021-08-03. Archived from the original on 2021-08-04. Retrieved 2021-09-03.

aljazeera.com

Motamedi M (29 December 2020). "COVIran Barakat: Iran launches human trials of its COVID vaccine". Al Jazeera. Archived from the original on 31 January 2021.
Motamedi M (2021-06-21). "Iran's Supreme Leader Khamenei receives local COVID vaccine". www.aljazeera.com. Archived from the original on 2021-06-25. Retrieved 2021-09-04.

bbc.com

Ardalan S (6 December 2020). "واکسن ایرانی کرونا تا 'تیر ماه آینده می‌رسد'" [Iranian corona vaccine will arrive by 'next July']. BBC News (in Persian). Archived from the original on 2020-12-06. Retrieved 2020-12-18.

bloomberg.com

Haghdoost H (17 February 2021). "Iran Vaccine Boasts Total Protection Against U.K. Covid Strain". bloomberg. Archived from the original on 2021-04-15. Retrieved 2021-04-08.

bmj.com

bmjopen.bmj.com

Minoo Mohraz et al. Safety and immunogenicity of aninactivated virus particle vaccine forSARS-CoV-2, BIV1-CovIran: findingsfrom double-blind, randomised, placebo-controlled, phase I and IIclinical trials among healthy adults BMJ Open, 2022

doi.org

Abdoli A, Aalizadeh R, Aminianfar H, Kianmehr Z, Teimoori A, Azimi E, et al. (May 2022). "Safety and potency of BIV1-CovIran inactivated vaccine candidate for SARS-CoV-2: A preclinical study". Reviews in Medical Virology. 32 (3): e2305. doi:10.1002/rmv.2305. PMC 8646699. PMID 34699647.
Mallapaty S (August 2021). "Iran hopes to defeat COVID with home-grown crop of vaccines". Nature. 596 (7873): 475. Bibcode:2021Natur.596..475M. doi:10.1038/d41586-021-02216-z. PMID 34404947. S2CID 237198729.
Salehi M, Hosseini H, Jamshidi HR, Jalili H, Tabarsi P, Mohraz M, et al. (June 2022). "Assessment of BIV1-CovIran inactivated vaccine-elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern". Clinical Microbiology and Infection. 28 (6): 882.e1–882.e7. doi:10.1016/j.cmi.2022.02.030. PMC 8893932. PMID 35248745.
Abdoli A, Aalizadeh R, Aminianfar H, Kianmehr Z, Azimi E, Emamipour N, et al. (January 2021). "Safety and Potency of COVIran Barekat Inactivated Vaccine Candidate for SARS-CoV-2: A Preclinical Study". bioRxiv 10.1101/2021.06.10.447951.
Mohraz M, Salehi M, Tabarsi P, Abbasi-Kangevari M, Ghamari SH, Ghasemi E, et al. (April 2022). "Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults". BMJ Open. 12 (4): e056872. doi:10.1136/bmjopen-2021-056872. PMC 8995575. PMID 35396297.
Mohraz M, Vahdat K, Ghamari SH, Abbasi-Kangevari M, Ghasemi E, Ghabdian Y, et al. (September 2023). "Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial". BMJ. 382: e070464. doi:10.1136/bmj-2023-070464. PMC 10520577. PMID 37734752. S2CID 262068839.

efe.com

"Irán dona a Nicaragua 200.000 dosis de vacunas contra la covid-19".

el19digital.com

"Nicaragua recibe 200 mil dosis de la vacuna Coviran donadas por Irán". El 19 Digital (in Spanish). Retrieved 2022-07-10.

farsnews.ir

"تولید ۶۰ میلیون دُز واکسن برکت در شفافارمد/ آغاز مطالعه بالینی واکسن اختصاصی اُمیکرون | خبرگزاری فارس" [Production of 60 million doses of Barakat vaccine in Shafafarmed / Initiation of clinical study of Omicron specific vaccine]. www.farsnews.ir (in Persian). 2022-02-26. Retrieved 2022-02-27.
"افتتاح اولین صندوق قرض‌الحسنه اشتغال کشور توسط ستاد اجرایی فرمان امام/ تولید 5 میلیون واکسن "برکت" تاکنون" [Inauguration of the first loan fund of the country by the executive headquarters of Farman Imam / Production of 5 million "Barakat" vaccines so far]. farsnews.ir (in Persian). Retrieved 27 July 2021.
"FarsNews Agency Ayatollah Khamenei Receives Iran-Made Coronavirus Vaccine". www.farsnews.ir. 2021-06-25. Archived from the original on 2021-06-25. Retrieved 2021-09-03.
"خبرگزاری فارس - آغاز کارآزمایی بالینی واکسن برکت پلاس". خبرگزاری فارس. 2022-03-02. Retrieved 2022-03-03.

france24.com

"Iran records over 500 Covid deaths, hits new high". France 24. 2021-08-08. Retrieved 2021-09-04.

harvard.edu

ui.adsabs.harvard.edu

Mallapaty S (August 2021). "Iran hopes to defeat COVID with home-grown crop of vaccines". Nature. 596 (7873): 475. Bibcode:2021Natur.596..475M. doi:10.1038/d41586-021-02216-z. PMID 34404947. S2CID 237198729.

indiatimes.com

health.economictimes.indiatimes.com

"Iran begins first human trial of locally made virus vaccine". health.economictimes.indiatimes. 29 December 2019. Archived from the original on 3 February 2021.

irannewspaper.ir

old.irannewspaper.ir

"تزریق واکسن ایرانی به "دختر" سازنده". old.irannewspaper.ir. Retrieved 2023-09-30.

iranpress.com

"COVIran Barekat to be exported to Nicaragua". iranpress.com. Retrieved 2022-03-17.

iranwire.com

Khoshhal P (21 January 2021). "Coronavirus Tzar Forced to Apologize to Clergy". iranwire. Archived from the original on 2021-01-21.

irct.ir

en.irct.ir

"IRCT | A Clinical trial to evaluate the immunogenicity and safety of Omicron-Based CovIran Barkat vaccine as a third injection dose in vaccinated population over 18 years of age". en.irct.ir. Retrieved 2022-03-03.
"IRCT | A double-blind, randomized, placebo-controlled Phase II/III Clinical trial to evaluate the safety and efficacy of COVID-19 inactivated vaccine (Shifa-Pharmed) in a population aged 18 to 75 years". en.irct.ir. Iranian Registry of Clinical Trials (IRCT). Archived from the original on 2021-04-23. Retrieved 2021-04-07.
"IRCT | A double-blinded, randomized, placebo-controlled Phase I Clinical trial to evaluate the safety and immunogenicity of COVID-19 inactivated vaccine (Shif-Pharmed) in a healthy population". en.irct.ir. Retrieved 2021-08-27.
"IRCT | A double-blind, randomized, placebo-controlled Phase I Clinical trial to evaluate the safety and immunogenicity of COVID-19 inactivated vaccine (Shifa-Pharmed) in a healthy population aged 51-75 years". en.irct.ir. Retrieved 2021-08-27.
"IRCT | Comparison of the tolerability, safety, and immunogenicity of Shifa-Pharmed COVID-19 inactivated vaccine (CovIran) and Sinopharm vaccine in the healthy population aged 12 to 18 years: a double-blind, randomized, active-controlled, Phase I-II clinical trial". en.irct.ir. Retrieved 2021-11-27.

irinn.ir

"آغاز مرحله سوم تست انسانی کووایران برکت" [The beginning of the third stage of the human test of COVIran Barakat]. Islamic Republic of Iran News Network (in Persian). Archived from the original on 2021-06-26. Retrieved 21 April 2021.

irna.ir

"دکتر رئیسی نخستین دُز واکسن کوو ایران برکت را دریافت کرد" [Dr. Raisi received the first dose of Iran-Barakat vaccine]. ایرنا (in Persian). 2021-08-08. Archived from the original on 2021-09-03. Retrieved 2021-09-03.
"نخستین محصول تولید انبوه واکسن "کوو ایران برکت" فردا رونمایی می‌شود" [The first mass-produced product of "Koo Iran Barakat" vaccine will be unveiled tomorrow]. irna (in Persian). 10 May 2021. Archived from the original on 17 May 2021. Retrieved 26 June 2021.
"کارآزمایی بالینی کُوو ایران برکت؛ نخستین واکسن ایرانی کرونا". www.irna.ir (in Persian). January 8, 2021. Retrieved 2023-09-30.
"واکسن ایران برکت احتمالا تا پایان خرداد ۱۴۰۰ به دست هموطنان می‌رسد" [Iran Barakat vaccine will probably reach our compatriots by the end of June 1400]. Iranian Students News Agency (in Persian). 24 March 2021. Archived from the original on 26 June 2021.
Omicron-specific Barkat vaccine was developed IRNA, Retrieved 6 March 2022

en.irna.ir

"Some foreign states willing to cooperate in COVIran Barakat clinical test: Official". irna. 30 March 2021. Archived from the original on 2021-03-31. Retrieved 2021-04-07.

isna.ir

"جزئیات مطالعه بالینی واکسن "کووایران برکت" منتشر شد + نتایج". ایسنا (in Persian). 2021-06-16. Retrieved 2021-08-31.
"موفقیت واکسن ایرانی در خنثی کردن "ویروس جهش‌یافته انگلیسی"" [Iranian vaccine succeeds in neutralizing "British mutated virus]. Iranian Students News Agency (in Persian). 30 January 2021. Archived from the original on 26 June 2021.
"قالیباف واکسن برکت دریافت کرد" [Qalibaf received the blessed vaccine]. ایسنا (in Persian). 2021-08-07. Retrieved 2021-09-03.

en.isna.ir

"Clinical trials of COVIRAN vaccine enter phases 2, 3". Iranian Students News Agency. 15 March 2021. Archived from the original on 11 May 2021. Retrieved 8 April 2021.
"Leader receives second dose of Iranian COVID-19 vaccine". ISNA. 2021-07-23. Retrieved 2021-09-03.

khabaronline.ir

"ببینید | تحویل 50 میلیون دُز واکسن "کوو ایران برکت" تا پایان شهریور - خبرآنلاین". www.khabaronline.ir. 2021-07-03. Archived from the original on 2021-08-13. Retrieved 2021-08-29.

latimes.com

Bulos N (19 January 2021). "Iranians demand a COVID-19 vaccine, not politics, from their leaders". Los Angeles Times. Archived from the original on 2021-01-19.

mashreghnews.ir

"عکس/ تزریق واکسن برکت به آملی لاریجانی" [Blessed vaccine injection to Amoli Larijani]. مشرق نیوز (in Persian). 2021-08-04. Retrieved 2021-09-03.

mehrnews.com

en.mehrnews.com

"Iran to kick off production of 3mn doses of COVIRAN". Mehr News Agency. 2021-03-15. Archived from the original on 2021-03-15. Retrieved 2021-04-07.

mojnews.com

"تعداد واکسن‌های تولید شده کوو ایران برکت به ۸ میلیون دز رسید". خبرگزاری موج (in Persian). 2021-08-30. Archived from the original on 2021-09-04. Retrieved 2021-09-08.

nicaraguaactual.tv

Prensa Nicaragua Actual (2022-06-22). "Nicaragua recibe primer lote de vacuna iraní contra el coronavirus COVIran Barekat". Nicaragua Actual (in Spanish). Retrieved 2022-07-10.

nih.gov

pubmed.ncbi.nlm.nih.gov

Abdoli A, Aalizadeh R, Aminianfar H, Kianmehr Z, Teimoori A, Azimi E, et al. (May 2022). "Safety and potency of BIV1-CovIran inactivated vaccine candidate for SARS-CoV-2: A preclinical study". Reviews in Medical Virology. 32 (3): e2305. doi:10.1002/rmv.2305. PMC 8646699. PMID 34699647.
Mallapaty S (August 2021). "Iran hopes to defeat COVID with home-grown crop of vaccines". Nature. 596 (7873): 475. Bibcode:2021Natur.596..475M. doi:10.1038/d41586-021-02216-z. PMID 34404947. S2CID 237198729.
Salehi M, Hosseini H, Jamshidi HR, Jalili H, Tabarsi P, Mohraz M, et al. (June 2022). "Assessment of BIV1-CovIran inactivated vaccine-elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern". Clinical Microbiology and Infection. 28 (6): 882.e1–882.e7. doi:10.1016/j.cmi.2022.02.030. PMC 8893932. PMID 35248745.
Mohraz M, Salehi M, Tabarsi P, Abbasi-Kangevari M, Ghamari SH, Ghasemi E, et al. (April 2022). "Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults". BMJ Open. 12 (4): e056872. doi:10.1136/bmjopen-2021-056872. PMC 8995575. PMID 35396297.
Mohraz M, Vahdat K, Ghamari SH, Abbasi-Kangevari M, Ghasemi E, Ghabdian Y, et al. (September 2023). "Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial". BMJ. 382: e070464. doi:10.1136/bmj-2023-070464. PMC 10520577. PMID 37734752. S2CID 262068839.

ncbi.nlm.nih.gov

Abdoli A, Aalizadeh R, Aminianfar H, Kianmehr Z, Teimoori A, Azimi E, et al. (May 2022). "Safety and potency of BIV1-CovIran inactivated vaccine candidate for SARS-CoV-2: A preclinical study". Reviews in Medical Virology. 32 (3): e2305. doi:10.1002/rmv.2305. PMC 8646699. PMID 34699647.
Salehi M, Hosseini H, Jamshidi HR, Jalili H, Tabarsi P, Mohraz M, et al. (June 2022). "Assessment of BIV1-CovIran inactivated vaccine-elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern". Clinical Microbiology and Infection. 28 (6): 882.e1–882.e7. doi:10.1016/j.cmi.2022.02.030. PMC 8893932. PMID 35248745.
Mohraz M, Salehi M, Tabarsi P, Abbasi-Kangevari M, Ghamari SH, Ghasemi E, et al. (April 2022). "Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults". BMJ Open. 12 (4): e056872. doi:10.1136/bmjopen-2021-056872. PMC 8995575. PMID 35396297.
Mohraz M, Vahdat K, Ghamari SH, Abbasi-Kangevari M, Ghasemi E, Ghabdian Y, et al. (September 2023). "Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial". BMJ. 382: e070464. doi:10.1136/bmj-2023-070464. PMC 10520577. PMID 37734752. S2CID 262068839.

radiofarda.com

"خامنه‌ای پس از دریافت "واکسن ایرانی کرونا": واکسن خارجی هم ایرادی ندارد" [Khamenei after receiving the "Iranian corona vaccine": There is no problem with the foreign vaccine]. رادیو فردا (in Persian). Archived from the original on 2021-06-26. Retrieved 2021-06-26.

reuters.com

"Iran's leader gets locally made coronavirus vaccine shot". Reuters. 2021-06-25. Retrieved 2021-08-24.
"Iran starts human testing of first domestic COVID-19 vaccine". Reuters. 29 December 2019. Archived from the original on 12 January 2021.

semanticscholar.org

api.semanticscholar.org

Mallapaty S (August 2021). "Iran hopes to defeat COVID with home-grown crop of vaccines". Nature. 596 (7873): 475. Bibcode:2021Natur.596..475M. doi:10.1038/d41586-021-02216-z. PMID 34404947. S2CID 237198729.
Mohraz M, Vahdat K, Ghamari SH, Abbasi-Kangevari M, Ghasemi E, Ghabdian Y, et al. (September 2023). "Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial". BMJ. 382: e070464. doi:10.1136/bmj-2023-070464. PMC 10520577. PMID 37734752. S2CID 262068839.

setad.ir

Setad (EIKO) (2021-06-16). "خلاصه نتایج تست انسانی واکسن کوو ایران برکت" [Summary of the results of COVIran Barekat vaccine's clinical trials] (PDF). Retrieved 2021-09-05.
"اولین تصاویر از خط تولید واکسن کووایران برکت". setad.ir (in Persian). 2021-03-15. Retrieved 2021-09-01.
"رونمایی ازمحموله تولید انبوه واکسن "کوو ایران برکت"". setad.ir (in Persian). 2021-05-11. Retrieved 2021-09-01.
"فاز یک خط تولید واکسن برکت". setad.ir (in Persian). 2021-08-14. Retrieved 2021-09-01.
"انتشارخلاصه نتایج تست انسانی واکسن کوو ایران برکت برای نخستین‌بار". setad.ir (in Persian). 2021-06-16. Retrieved 2021-08-31.

shifapharmed.com

"About - شرکت گروه صنایع شفافارمد". 2021-04-15. Retrieved 2021-09-03.
"COVID-19 Vaccine (pharmaceutical product)". شرکت گروه صنایع شفافارمد (Shafafarmad Industries Group Company). 2021-04-19. Retrieved 2021-08-09.
"Growth Factor". شرکت گروه صنایع شفافارمد (Shafafarmad Industries Group Company). 2021-04-19. Retrieved 2021-08-09.

tasnimnews.com

"زیرساخت تولید ماهانه 25 تا 30 میلیون دوز واکسن برکت فراهم شده است + پاسخ به شبهات- اخبار پزشکی - اخبار اجتماعی تسنیم" [The infrastructure for the monthly production of 25 to 30 million doses of Barakat vaccine has been provided + Answering the suspicions - Medical news]. خبرگزاری تسنیم (Tasnim Social News) (in Persian). Retrieved 2021-08-24.
The production capacity of the Barakat vaccine reached 350 million doses per year Tasnimnews.com, Retrieved 26 April 2022
"دانش فنی واکسن برکت صد درصد ایرانی است/ تلاش ۶۵۰ نفر در ساخت واکسن ایرانی کرونا" [Vaccine technical knowledge is 100% Iranian / 650 people participated in developing Iranian COVID-19 vaccine]. Tasnim News Agency (in Persian). Archived from the original on 9 July 2021. Retrieved 2021-06-26.
"تولید 16 میلیون دوز واکسن برکت تا امروز/ ارائه مستندات برای اخذ مجوز سازمان جهانی بهداشت- اخبار پزشکی - اخبار اجتماعی تسنیم | Tasnim". خبرگزاری تسنیم | Tasnim (in Persian). Retrieved 2021-11-27.
"تست انسانی واکسن ایرانی کرونا آغاز شد/ وزیر بهداشت: ما با ۱۰۰ سال سابقه، اولین واکسن‌ساز آسیا هستیم" [Human test of Iranian corona vaccine begins / Minister of Health: We are the first vaccinator in Asia with 100 years of experience]. Tasnim News Agency (in Persian). Archived from the original on 26 June 2021.
"ایمنی‌زایی ۹۳.۵درصدی واکسن برکت در فاز دوم/ ۱۲ کشور برای خرید درخواست دادند" [93.5% immunity for Barakat vaccine in Phase II / 12 countries apply for purchase]. Tasnim News Agency (in Persian). Retrieved 24 June 2021.

tehrantimes.com

"Iranian-made vaccine against Omicron begins clinical trial". Tehran Times. 2022-03-02. Retrieved 2022-03-03.
"Iran starts mass-production of homegrown coronavirus vaccine". Tehran Times. 2021-03-15. Archived from the original on 2021-03-22. Retrieved 2021-04-07.
"COVIRAN begins clinical trial on children aged 12-18". Tehran Times. 2021-11-23. Retrieved 2021-11-27.
"Iran exports COVID-19 vaccines to Nicaragua". Tehran Times. 2022-06-22. Retrieved 2022-07-10.
"COVIRAN BAREKAT in process to WHO's registration". Tehran Times. 2021-07-25. Retrieved 2021-08-04.
"COVIRAN vaccine begins global registration process". Tehran Times. 2022-01-28. Retrieved 2022-03-03.
"CovIran Plus elicits protective neutralization against Omicron: study". Tehran Times. 2022-02-16. Retrieved 2022-03-03.

timesofisrael.com

Vahdat A (29 December 2020). "Iran begins human trials for locally made coronavirus vaccine". Times of Israel. Archived from the original on 16 January 2021. Retrieved 30 December 2020.

trend.az

en.trend.az

Baghishov E (14 June 2021). "Iran issues license on its coronavirus vaccine". Trend.Az. Archived from the original on 2021-06-14. Retrieved 14 June 2021.

tums.ac.ir

alumni.tums.ac.ir

"علامه طباطبایی استاد مينو محرز: هرچه دارم از دانشگاه علوم پزشكي تهران است" [Allameh Tabatabai | Professor Minoo Mehrz: Everything I have is from Tehran University of Medical Sciences] (in Persian). Tehran University of Medical Sciences Alumni Communication Office. Archived from the original on May 19, 2021. Retrieved March 29, 2017.

washingtonpost.com

Torbati Y (20 August 2022). "Amid covid surge, Iran cut corners to approve yet-unproven vaccine". The Washington Post. Retrieved 22 August 2022.

web.archive.org

Motamedi M (29 December 2020). "COVIran Barakat: Iran launches human trials of its COVID vaccine". Al Jazeera. Archived from the original on 31 January 2021.
Baghishov E (14 June 2021). "Iran issues license on its coronavirus vaccine". Trend.Az. Archived from the original on 2021-06-14. Retrieved 14 June 2021.
"دکتر رئیسی نخستین دُز واکسن کوو ایران برکت را دریافت کرد" [Dr. Raisi received the first dose of Iran-Barakat vaccine]. ایرنا (in Persian). 2021-08-08. Archived from the original on 2021-09-03. Retrieved 2021-09-03.
"IRCT | A double-blind, randomized, placebo-controlled Phase II/III Clinical trial to evaluate the safety and efficacy of COVID-19 inactivated vaccine (Shifa-Pharmed) in a population aged 18 to 75 years". en.irct.ir. Iranian Registry of Clinical Trials (IRCT). Archived from the original on 2021-04-23. Retrieved 2021-04-07.
"Iran begins first human trial of locally made virus vaccine". health.economictimes.indiatimes. 29 December 2019. Archived from the original on 3 February 2021.
"دانش فنی واکسن برکت صد درصد ایرانی است/ تلاش ۶۵۰ نفر در ساخت واکسن ایرانی کرونا" [Vaccine technical knowledge is 100% Iranian / 650 people participated in developing Iranian COVID-19 vaccine]. Tasnim News Agency (in Persian). Archived from the original on 9 July 2021. Retrieved 2021-06-26.
Ardalan S (6 December 2020). "واکسن ایرانی کرونا تا 'تیر ماه آینده می‌رسد'" [Iranian corona vaccine will arrive by 'next July']. BBC News (in Persian). Archived from the original on 2020-12-06. Retrieved 2020-12-18.
"علامه طباطبایی استاد مينو محرز: هرچه دارم از دانشگاه علوم پزشكي تهران است" [Allameh Tabatabai | Professor Minoo Mehrz: Everything I have is from Tehran University of Medical Sciences] (in Persian). Tehran University of Medical Sciences Alumni Communication Office. Archived from the original on May 19, 2021. Retrieved March 29, 2017.
"Iran starts human testing of first domestic COVID-19 vaccine". Reuters. 29 December 2019. Archived from the original on 12 January 2021.
"Iran starts mass-production of homegrown coronavirus vaccine". Tehran Times. 2021-03-15. Archived from the original on 2021-03-22. Retrieved 2021-04-07.
"نخستین محصول تولید انبوه واکسن "کوو ایران برکت" فردا رونمایی می‌شود" [The first mass-produced product of "Koo Iran Barakat" vaccine will be unveiled tomorrow]. irna (in Persian). 10 May 2021. Archived from the original on 17 May 2021. Retrieved 26 June 2021.
"Iran to kick off production of 3mn doses of COVIRAN". Mehr News Agency. 2021-03-15. Archived from the original on 2021-03-15. Retrieved 2021-04-07.
"ببینید | تحویل 50 میلیون دُز واکسن "کوو ایران برکت" تا پایان شهریور - خبرآنلاین". www.khabaronline.ir. 2021-07-03. Archived from the original on 2021-08-13. Retrieved 2021-08-29.
"تعداد واکسن‌های تولید شده کوو ایران برکت به ۸ میلیون دز رسید". خبرگزاری موج (in Persian). 2021-08-30. Archived from the original on 2021-09-04. Retrieved 2021-09-08.
"آغاز مرحله سوم تست انسانی کووایران برکت" [The beginning of the third stage of the human test of COVIran Barakat]. Islamic Republic of Iran News Network (in Persian). Archived from the original on 2021-06-26. Retrieved 21 April 2021.
Bulos N (19 January 2021). "Iranians demand a COVID-19 vaccine, not politics, from their leaders". Los Angeles Times. Archived from the original on 2021-01-19.
Khoshhal P (21 January 2021). "Coronavirus Tzar Forced to Apologize to Clergy". iranwire. Archived from the original on 2021-01-21.
Vahdat A (29 December 2020). "Iran begins human trials for locally made coronavirus vaccine". Times of Israel. Archived from the original on 16 January 2021. Retrieved 30 December 2020.
"Some foreign states willing to cooperate in COVIran Barakat clinical test: Official". irna. 30 March 2021. Archived from the original on 2021-03-31. Retrieved 2021-04-07.
"تست انسانی واکسن ایرانی کرونا آغاز شد/ وزیر بهداشت: ما با ۱۰۰ سال سابقه، اولین واکسن‌ساز آسیا هستیم" [Human test of Iranian corona vaccine begins / Minister of Health: We are the first vaccinator in Asia with 100 years of experience]. Tasnim News Agency (in Persian). Archived from the original on 26 June 2021.
"پایان تزریق فاز یک مطالعات واکسن کووایران برکت" [End of the injection of phase one (studies) of "Kovoo-Iran Barakat" vaccine]. Young Journalists Club (in Persian). Archived from the original on 17 July 2021. Retrieved 16 February 2021.
"Clinical trials of COVIRAN vaccine enter phases 2, 3". Iranian Students News Agency. 15 March 2021. Archived from the original on 11 May 2021. Retrieved 8 April 2021.
"واکسن ایران برکت احتمالا تا پایان خرداد ۱۴۰۰ به دست هموطنان می‌رسد" [Iran Barakat vaccine will probably reach our compatriots by the end of June 1400]. Iranian Students News Agency (in Persian). 24 March 2021. Archived from the original on 26 June 2021.
"خامنه‌ای پس از دریافت "واکسن ایرانی کرونا": واکسن خارجی هم ایرادی ندارد" [Khamenei after receiving the "Iranian corona vaccine": There is no problem with the foreign vaccine]. رادیو فردا (in Persian). Archived from the original on 2021-06-26. Retrieved 2021-06-26.
"جلیلی: واکسن کوو ایران برکت، ویروس انگلیسی را خنثی می‌کند" [Jalili: The Iranian vaccine neutralizes the British virus]. Young Journalists Club (in Persian). Archived from the original on 26 June 2021.
"موفقیت واکسن ایرانی در خنثی کردن "ویروس جهش‌یافته انگلیسی"" [Iranian vaccine succeeds in neutralizing "British mutated virus]. Iranian Students News Agency (in Persian). 30 January 2021. Archived from the original on 26 June 2021.
Haghdoost H (17 February 2021). "Iran Vaccine Boasts Total Protection Against U.K. Covid Strain". bloomberg. Archived from the original on 2021-04-15. Retrieved 2021-04-08.
"مجوز مصرف واکسن "کووایران برکت" صادر شد" [The license to use the "Kovairan Barakat" vaccine was issued]. Young Journalists Club (in Persian). Archived from the original on 26 June 2021. Retrieved 16 June 2021.
"FarsNews Agency Ayatollah Khamenei Receives Iran-Made Coronavirus Vaccine". www.farsnews.ir. 2021-06-25. Archived from the original on 2021-06-25. Retrieved 2021-09-03.
Motamedi M (2021-06-21). "Iran's Supreme Leader Khamenei receives local COVID vaccine". www.aljazeera.com. Archived from the original on 2021-06-25. Retrieved 2021-09-04.
"علی لاریجانی واکسن ایرانی تزریق کرد" [Ali Larijani is injected with the Iranian vaccine]. جامعه خبری تحلیلی الف (in Persian). 2021-08-03. Archived from the original on 2021-08-04. Retrieved 2021-09-03.

who.int

extranet.who.int

"Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process". 2 March 2022. Retrieved 2022-03-03.

yjc.ir

"Good News About AIDS". Young Journalists Club. February 6, 2016. Retrieved 2020-02-26.
"پایان تزریق فاز یک مطالعات واکسن کووایران برکت" [End of the injection of phase one (studies) of "Kovoo-Iran Barakat" vaccine]. Young Journalists Club (in Persian). Archived from the original on 17 July 2021. Retrieved 16 February 2021.

yjc.news

"جلیلی: واکسن کوو ایران برکت، ویروس انگلیسی را خنثی می‌کند" [Jalili: The Iranian vaccine neutralizes the British virus]. Young Journalists Club (in Persian). Archived from the original on 26 June 2021.
"مجوز مصرف واکسن "کووایران برکت" صادر شد" [The license to use the "Kovairan Barakat" vaccine was issued]. Young Journalists Club (in Persian). Archived from the original on 26 June 2021. Retrieved 16 June 2021.